Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.435

-2.4%

Dec 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RockyBalboa who wrote (1112)	5/18/1999 8:00:00 AM
From: Mama Bear	Read Replies (1) of 10293

IS, please notice how HEB management is railing against short sellers, and has gotten AIDs activists and researchers involved in the same. "''Stockbrokers who make millions short selling biotechnology companies, like Hemispherx, could potentially deny humanity developing drugs that can alleviate suffering and treat disease,'' says Jim Livigni, a Senior Editor of the International Chronicle of Therapeutic Developments in AIDS Research. ''In the case of Hemispherx, short sellers could delay the development of potentially promising therapeutic agents for HIV and other diseases.''" biz.yahoo.com As if the price of the stock in the secondary market has a direct bearing on whether or not the drug works. I think that's vice versa. Barb

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next